본문 바로가기

Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
ADVANCED DRUG DELIVERY REVIEWS176 · #113887 · 2021
피인용
Web of Science 191Scopus 205
FWCI (Scopus)
3.23
JCR IF
JCR 2020 15.47
ISSN
0169-409X

저자

  1. Zu, Menghang제1저자Southwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China
  2. Ma, YaSouthwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China
  3. Cannup, BrandonGeorgia State Univ, Inst Biomed Sci, Digest Dis Res Grp, Atlanta, GA 30302 USA
  4. Xie, DengchaoSouthwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China
  5. 정연진Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
  6. Zhang, JinmingChengdu Univ Tradit Chinese Med, Sch Pharm, State Key Lab Southwestern Chinese Med Resources, Chengdu 611137, Sichuan, Peoples R China
  7. Yang, ChunhuaGeorgia State Univ, Inst Biomed Sci, Digest Dis Res Grp, Atlanta, GA 30302 USA
  8. Gao, Fei교신저자Chengdu Univ Tradit Chinese Med, Sch Pharm, State Key Lab Southwestern Chinese Med Resources, Chengdu 611137, Sichuan, Peoples R China
  9. Merlin, Didier교신저자Georgia State Univ, Inst Biomed Sci, Digest Dis Res Grp, Atlanta, GA 30302 USA
  10. Xiao, Bo교신저자Southwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China

초록

The incidence of inflammatory bowel disease (IBD) is rapidly rising throughout the world. Although tremendous efforts have been made, limited therapeutics are available for IBD management. Natural active small molecules (NASMs), which are a gift of nature to humanity, have been widely used in the prevention and alleviation of IBD; they have numerous advantageous features, including excellent biocompatibility, pharmacological activity, and mass production potential. Oral route is the most common and acceptable approach for drug administration, but the clinical application of NASMs in IBD treatment via oral route has been seriously restricted by their inherent limitations such as high hydrophobicity, instability, and poor bioavailability. With the development of nanotechnology, polymeric nanoparticles (NPs) have provided a promising platform that can efficiently encapsulate versatile NASMs, overcome multiple drug delivery barriers, and orally deliver the loaded NASMs to targeted tissues or cells while enhancing their stability and bioavailability. Thus, NPs can enhance the preventive and therapeutic effects of NASMs against IBD. Herein, we summarize the recent knowledge about polymeric matrix based carriers, targeting ligands for drug delivery, and NASMs. We also discuss the current challenges and future developmental directions. (c) 2021 Elsevier B.V. All rights reserved.

키워드

Inflammatory bowel diseaseOral administrationPolymeric nanoparticleTargeting ligandNatural active small moleculeSILK FIBROIN NANOPARTICLESPH-SENSITIVE NANOPARTICLESCOLON-TARGETED DELIVERYINDUCED EXPERIMENTAL COLITISDRUG-DELIVERYULCERATIVE-COLITISDOUBLE-BLINDIN-VITROBIODEGRADABLE NANOPARTICLESMACROMOLECULAR PRODRUGS

식별자

Scopus EID
2-s2.0-85111581819
WoS UID
000697164900010